Covered recipient · General Payments record
TAMEKA R LEE
Podiatric Medicine & Surgery Service Providers Podiatrist Foot Surgery
General Payments · PY2018–2024
$1,649.62
- Reported across 93 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $583.07 | 23 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $263.49 | 9 |
| DEXCOM, INC. | $81.48 | 4 |
| Linvatec Corporation | $56.69 | 1 |
| Novo Nordisk AS | $52.44 | 3 |
| Stryker Corporation | $42.79 | 1 |
| Abbott Laboratories | $34.77 | 2 |
| Corcept Therapeutics | $21.04 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.34 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (23)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.61 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125352770 | CMS |
| Abbott Laboratories | $17.16 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125352772 | CMS |
| Amgen Inc. | $22.84 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608530 | CMS |
| Amgen Inc. | $21.68 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608532 | CMS |
| Amgen Inc. | $12.71 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608534 | CMS |
| Amgen Inc. | $4.73 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115860785 | CMS |
| Amgen Inc. | $19.71 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608536 | CMS |
| Amgen Inc. | $22.26 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117608538 | CMS |
| Amgen Inc. | $21.98 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115860793 | CMS |
| Amgen Inc. | $121.82 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115860810 | CMS |
| Amgen Inc. | $15.76 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115860802 | CMS |
| Corcept Therapeutics | $21.04 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117748279 | CMS |
| Dexcom, Inc. | $23.33 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339687 | CMS |
| Dexcom, Inc. | $14.39 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339689 | CMS |
| Dexcom, Inc. | $21.08 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339691 | CMS |
| Dexcom, Inc. | $22.68 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153339693 | CMS |
| Linvatec Corporation | $56.69 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147086764 | CMS |
| Novo Nordisk Inc | $13.91 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919704 | CMS |
| Novo Nordisk Inc | $13.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096895091 | CMS |
| Novo Nordisk Inc | $24.89 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096937129 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.34 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153637868 | CMS |
| Stryker Corporation | $42.79 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119892020 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.03 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151540147 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.